Description
Introduction
Drug Delivery Systems mean technology used to take a therapeutic quantity of drugs to the site of action in the human body to take its effect. The syringe was developed in 1855 and is considered the first such equipment. There are two aspects of an ideal drug delivery system: Spatial Placement and Temporal delivery of the drug. The first one refers to the ability of the drug to target a specific issue and the second one refers to the rate of controlling the amount of drug intake to take the best effect and avoid overdose which could create complications
End User/Technology
Reservoir Systems like capsules or tablets have a drug reservoir surrounded by a coat of retardant barriers. There are four mechanisms by which this process works: Diffusion of drugs through the barrier, Penetration of the elution media through the barrier into the reservoir, Timed erosion of the barrier and Rupture of the barrier
Market Dynamics
Onsite action, reduced dosages,the higher success rate in therapy are some advantages over conventional drug delivery. Increase R&D in clinical trials and government support for these are fueling the advanced drug delivery market. Strong regulations in advanced countries, the high price in developed countries and non-availability in some African nations are some restraints. The global spintronics market will be 227.3 billion USD by 2020 with a CAGR of 4.9%. The North American and the European Market grew at a CAGR of 4.7% and 4.3% respectively.
Market segmentation
Based on the technology:
- Polymerized drug delivery
- Implants and IUDs
- Sustained release
- Targeted Drug Delivery
- Prodrugs
Based on geography
- Asia-Pacific
- Europe
- North America
- Rest of The World
Based on polymeric drug delivery
- Nebulizers
- Metered dose inhalers
- Dry powdered inhalers
Regional/Geographic Analysis
North America and Europe possess the most advanced drug delivery system technologies. The developing countries like India and China are major markets for drug delivery systems because of rising population and rising disposable income.
Key Players
- NeXstar Pharmaceuticals Inc
- West Pharmaceuticals
- 3M
- Novartis International AG
- Market segments
- Market Drivers, Restraints and Opportunities
- Market Size & Forecast 2016 to 2022
- Supply & Demand Value Chain
- Market – Current Trends
- Competition & Major Companies
- Technology and R&D Status
- Porters Five Force Analysis
- Strategic and Critical Success Factor Analysis of Key Players
- North America
- US and Canada
- Latin America
- Mexico, Brazil, Argentina and Rest of Latin America
- Western Europe
- EU5 (Germany, France, Italy, Spain, U.K.)
- Nordic Countries (Denmark, Finland, Norway, and Sweden)
- Benelux (Belgium, The Netherlands, and Luxembourg)
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
- Asia Pacific
- China
- India
- Japan
- Australia and New Zealand
- Rest of Asia Pacific
- Middle East and Africa
- GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
- South Africa
- North Africa
- Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
- Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
- Consumer and Pricing Analysis
- Market dynamics of the industry
- Market Segmentation
- Estimated Market Sizing in terms of volume and value
- Recent trends in Market and impact
- Research Status and Technology Overview
- Extensive Industry Structure Coverage
